United States · FDA National Drug Code directory
Cefpodoxime Proxetil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16714-403_3c3d4973-bfda-476f-b094-52ac4648d7f8
- Product NDC
- 16714-403
- Form
- GRANULE, FOR SUSPENSION
- Composition / generic term
- Cefpodoxime Proxetil
- Labeler
- NorthStar Rx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070608
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFPODOXIME PROXETIL — 100 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (16714-403-01) / 50 mL in 1 BOTTLE · 16714-403-01
- 1 BOTTLE in 1 CARTON (16714-403-02) / 100 mL in 1 BOTTLE · 16714-403-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →